Loading...
PI3K at the crossroads of tumor angiogenesis signaling pathways
Tumors need blood vessels for their growth, thus providing the rationale for antiangiogenic therapy in cancer treatment. However, intrinsic and acquired resistance and low response rates have turned out to be major limitations of antiangiogenic therapy. This emphasizes the need to further understand...
Saved in:
| Published in: | Mol Cell Oncol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
Taylor & Francis
2015
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4905058/ https://ncbi.nlm.nih.gov/pubmed/27308431 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/23723556.2014.975624 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|